CONDITION EDUCATION · PRELIMINARY CONDITION-SPECIFIC EVIDENCE
Heart Failure and Circulation
Heart failure changes how the heart fills and pumps blood. This page explains the circulation mechanism, EECP’s demonstrated circulation effects, and the distinct preliminary evidence question for heart failure.
CLAIM 2 — ESTABLISHED
Heart failure changes forward flow and filling pressure
Heart failure is a complex clinical syndrome in which structural or functional impairment of ventricular filling or ejection of blood can produce symptoms and signs. The heart may not fill with enough blood, may not pump effectively enough, or both.[1][2]
Impaired pumping can reduce forward blood flow while pressure rises behind the heart. Elevated filling pressures and congestion are part of the clinical picture, helping explain why breathlessness, fatigue, and swelling can occur.[1][2]
CLAIM 1 — STRONG
EECP improves circulation through cardiac-cycle timing
Enhanced external counterpulsation (EECP), also called external counterpulsation (ECP), is a noninvasive, ECG-timed cuff therapy.
EECP uses pneumatic cuffs that inflate sequentially during diastole and deflate before systole. This produces diastolic augmentation, increases venous return, and reduces systolic vascular load.[m1]
In controlled coronary-disease research, EECP improved measured endothelial function compared with sham treatment, and a randomized study reported increased coronary collateral flow after treatment. These studies support the strong therapy-level circulation claim.[m2][m3]
EVIDENCE BOX — CLAIM 3
EECP for heart failure: Preliminary evidence
The PEECH randomized, single-blinded trial assigned 187 people with mild-to-moderate heart-failure symptoms to EECP plus protocol-defined pharmacologic therapy or pharmacologic therapy alone. At six months, 35% of the EECP group and 25% of the control group achieved an increase of at least 60 seconds in exercise duration.[3]
The trial found no between-group difference in change in peak oxygen consumption, one of its two co-primary endpoints. Functional class improved at follow-up time points in the active-treatment group. This is meaningful direct evidence, but a single trial in a defined population does not establish EECP as a demonstrated treatment across heart-failure types or stages.[3]
URGENT SAFETY
Severe chest pain or severe breathing difficulty needs immediate care
Call 911 for severe chest pain or severe difficulty breathing. These can be medical emergencies.[4]
CONTINUE LEARNING
Choose the next useful educational step.
COMMON QUESTIONS
Frequently asked questions
How is circulation involved in heart failure?
Heart failure can affect ventricular filling, pumping, forward blood flow, and filling pressures. Those circulation changes are part of the syndrome’s physiology.[1][2]
Why is the direct EECP evidence preliminary?
The direct evidence includes a randomized trial in a defined mild-to-moderate heart-failure population, but one of its co-primary endpoints did not differ between groups. It does not establish outcomes across heart-failure types or stages.[3]
REFERENCES
Sources
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- American Heart Association: What Is Heart Failure?
- Feldman et al.: Enhanced external counterpulsation improves exercise tolerance in chronic heart failure
- American Heart Association: When to Call 911
- Michaels et al.: Intracoronary pressure and Doppler flow during EECP
- Braith et al.: EECP flow-mediated dilation randomized sham-controlled study
- Gloekler et al.: Coronary collateral growth by external counterpulsation